ENGlobal’s service line-up is enough to make any engineer directly involved in the energy industry sit up and take notice. The company’s expertise runs wide and deep on its road toward sustainable growth and ultimately shareholder value. Players in the energy sector are beneficiaries of ENG’s expertise in the areas of energy and construction, automation integration, automation engineering and design and subsea controls and integration.

ENGlobal’s synthetic gas experience within its Construction and Engineering branch includes key facilities design and consulting projects for gasification, hydrogen facilities, gas-to-liquids and ammonia facilities to name a few.

With respect to gasification of biomass, the company has developed a study which reveals the feasibility of designing, purchasing and constructing a Biomass to Energy (BTE) project in the United States. The study contains analysis of the design, procurement and construction of the BTE plant and a preliminary heat and material balance showing the amount of power potentially generated from the syngas – a mixture of carbon monoxide and hydrogen.

Another emerging source for alternative fuel production is in the area of gas-to-liquids. The company has in its possession a feasibility study for the use of Fischer-Tropsch (F-T) reactors to convert natural gas into liquid transportation fuels; ultra-low sulfur diesel in particular. The process involves natural gas being introduced to a steam-methane reformer to create SYNGAS. The SYNGAS then reacts with a catalyst in the F-T reactor to form F-T wax. As the process progresses, the wax is then hydrocracked and used in refining technology to produce transportation fuels.

ENGlobal’s range of services in the synthetic gas space go from conceptual engineering and feasibility studies to detailed design, construction management, permitting, third party operations and maintenance and program management. Leveraging experience in refining and petrochemical processing, the company is known for delivering the industry’s finest solutions to its customer base regarding renewable projects.

ENGlobal provides engineering and related project services to the energy sector throughout the United States and world. ENGlobal operates through its Automation and Engineering segments. The company’s Automation segment delivers services related to the design, fabrication and implementation of advanced automation, control, instrumentation and process analytical systems. The Engineering segment provides consulting services for the development, management and execution of projects requiring professional engineering, construction management, and a wide variety of ancillary support and services.

For more information on the company, visit www.ENGlobal.com

Trans-Lux Corp. is a leading designer and manufacturer of digital display solutions. The company’s TL Vision digital video displays and TL Energy LED lighting solutions are marketed to a variety of industries in which digital signage is a viable business tool – including the financial, sports and entertainment, gaming, education, government and commercial markets. Offering a comprehensive collection of LED large screen systems, LCD flat panel displays, data walls and scoreboards, Trans-Lux is able to effectively provide digital display products for virtually every venue.

Since being founded in 1920, Trans-Lux has developed a formidable position in the evolving electronic display market. Within the last year, the company has successfully leveraged this position to provide dynamic displays to a collection of clients in high-profile venues, such as Soldier Field in Chicago and Times Square in New York. In particular, Trans-Lux’s three phase project in New York is expected to account for more than $2.5 million in total revenue.

“Trans-Lux was first to bring LED technology to the Times Square area, and we continue to deliver new and innovative LED display and lighting solutions to help maintain its reputation as the crossroads of the world,” J. M. Allain, president and chief executive officer of Trans-Lux, stated in a news release. “Our TL Vision LED displays provide a highly visible and effective media platform to engage and drive customer traffic with HD quality imagery and messaging.”

In the years to come, the digital signage industry is expected to experience accelerated growth, putting Trans-Lux into a strong strategic position to expand its current market share. According to a report by InfoTrends, businesses that utilize digital signage realize a 31.7 percent increase in overall sales. Likewise, an impressive 63 percent of people reported that digital signage is effective in catching their attention.

In the first quarter of 2015, Trans-Lux provided a glimpse of its growth potential by recording strong financial results, achieving a quarter-of-quarter increase in gross profit of nearly 50 percent. The company built on this progress in June by announcing the opening of a new design and production facility in Shenzhen, China, as well as the formation of new technology partnerships with two of the world’s leading LED suppliers.

“Our new design and production resources in China, and the addition of two highly renowned technology partners, further support the continued growth of Trans-Lux on a global scale,” continued Allain. “Our new manufacturing facility in China complements our manufacturing capabilities here in the U.S. and allows us to accelerate delivery times with better quality controls.”

For prospective shareholders, Trans-Lux’s recent commitment to expanding its industry presence could provide a platform for strong investor returns moving forward. Look for the company to lean on the competitive advantages provided by its new international manufacturing capabilities in order to expand its market share in the months to come.

For more information, visit www.trans-lux.com

Wisdom Homes of America, an owner and operator of manufactured homes retail centers in Texas, announces that it has engaged the investor relations services of QualityStocks. Based in Scottsdale, Arizona, QualityStocks has assisted more than 300 public companies with their efforts to broaden influence, attract growth capital and improve shareholder value.

“So far, 2015 has been a strong year in terms of brand exposure and growing our revenues,” stated Brent Nelms, president of Wisdom Homes of America. “The market for manufactured housing is flourishing as a growing number of today’s consumers seek-out high quality manufactured homes that won’t break the bank. With Wisdom Homes, aesthetic appeal and solid functionality never have to be sacrificed in the name of affordability. As we continue to grow our physical presence and capture our share of this growing market, we need a loud voice to relay our progress to existing and potential shareholders — we’ve selected QualityStocks to be that voice.”

QualityStocks will use its powerful network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools to raise awareness of Wisdom Homes of America’s current operations, achievements and future expansion plans to the investment community.

“Wisdom Homes of America has an incredible product positioned in a high-potential market, and the proof is in the numbers,” stated QualityStocks Managing Director Michael McCarthy. “As the company previously announced, it is on track to achieve revenues of at least $4 million by year end, its first full year owning and operating its manufactured home retail centers. As a trusted partner, the QualityStocks team will broadcast the brand and its potential to the investment community. Using our vast networks, resources, tools and experience, we will raise awareness of the Wisdom Homes brand and communicate the company’s achievements to current and future investors.”

For more information, visit www.wisdomhomesofamerica.com

Let us hear your thoughts: Wisdom Homes of America, Inc. Message Board

With a legal market size last year of around $2.7 billion, which is projected to expand by a whopping 300 percent over the next four years to around $10.8 billion according to a recent report from ArcView Market Research, the market for cannabis in the U.S. is fueling one of the fastest growing industries the country has to offer. Given that there is yet considerable room for expansion nationwide, as well as positive/widespread consumer sentiment that continues to drive legislative easing of legal restrictions on both medical and recreational use, the industry is primed to blossom nationally, from medical marijuana (MMJ) being legal in just 23 states, D.C. and the territory of Puerto Rico, and recreational use being allowed in Alaska, Colorado, D.C., Oregon and Washington.

The profound benefits of easily tolerable and safe medicines based on established and emerging cannabis science, which have been demonstrated thus far in areas like epilepsy, largely speak for themselves and this vector is an extremely important one for the future of the industry as well, as it will continue to be the narrow end of the wedge for the development of the broader market. This market will eventually contain a rich variety of everything from edibles and extracts by developers like Nutritional High International (OTCQB: SPLIF), to frontline cannabinoid medicines from companies like GW Pharmaceuticals (NASDAQ: GWPH), such as the multiple sclerosis-related spasticity drug Sativex®, or the recently FDA Orphan Drug Designation approved Epidiolex©, designed to treat severe forms of epilepsy.

Another major driver of legislative reform on this issue has of course been tax revenue and with Washington recently noting how it has successfully emulated Colorado’s own achievements in this area, raking in some $250 million in sales over the past year and realizing around $62 million in excise taxes (a figure 72 percent higher than initially forecast), it doesn’t take a rocket scientist to figure out what the future of the cannabis industry here in America will look like. Indeed, it feels like the end of the alcohol prohibition era to many investors and some of the small to mid-cap companies out there today, who are still just cutting their teeth, could be tomorrow’s juggernauts, rivaling some of the top players in the $170 billion plus U.S. alcoholic beverages market, like Anheuser-Busch InBev (NYSE: BUD), Diageo (NYSE: DEO), and Molson Coors (NYSE: TAP).

The key to maturing into such a juggernaut however is a difficult to pull off combination of visionary business modeling, talented personnel, logistical capacity, marketing, understanding of the end-user dynamics, and most importantly the quality of the product itself. This is where an up-and-coming biopharma development company with strong roots in cutting-edge plant biology and cultivation technology like GrowBLOX Sciences (OTC: GBLX) really shines. With an integrated approach to the market, spanning its proprietary grow technology based on tissue sample-based cloning and a controlled environment that yields consistently high-grade product, which is ideal for both consumers and pharma development purposes alike, through to a well-thought-out commercialization and marketing strategy, GBLX is one of the few “pot stocks” around today with a full-spectrum approach to the industry that could emerge as a one of tomorrow’s sector juggernauts.

By leveraging the company’s proprietary TissueBLOX, GrowBLOX, and CureBLOX platforms, GBLX is able to deliver genetically consistent, high-grade strains of certified raw cannabis materials and blends that will not only resonate with consumers in the end markets and fetch premium prices, while simultaneously priming the pump for accelerated human trialing of cannabis-based medicines. Because the company’s lab-based analytical methods allow GBLX to make precise determinations about key strains and the profile of active ingredients in those strains, and because of the company’s tight post-processing via its ExtractionLAB technology, GrowBLOX Sciences is effectively at the forefront of cannabis drug discovery capabilities, due to its ability to target and cultivate the best strains, and to do so in an environment which eliminates almost all of the variables that otherwise represent risk factors that must be compensated for.

Able to reduce the typical 15 to 20 year development window and billion plus required to bring a new drug to market, GBLX’s accelerated drug discovery program harnesses in-house strain science, the ability to cultivate genetically pure and identical plants, as well as the processing technology needed to rapidly establish FDA FastTrack Approvals or Orphan Drug designations. Moreover, the company’s GBLX-PRO app leverages Big Data harvesting techniques in order to create a real-time feedback loop with end-users, allowing for the rapid establishment of highly coordinated strain profile information, cannabis safety profiling, and usage-based symptom relief data. Cannabis-based medicine development targets run the gamut from cancer treatments, cardio protection, compromised immune system products and inflammation fighters, to indications for treating metabolic syndrome, neurological disorders like epilepsy, and more standard fare such as pain management.

The combination of this accelerated drug discovery pipelining solution with the revenue potential from consistently high-grade materials and blends output to the dispensary market is only the beginning of the story for GBLX though, as the company has already shipped out production-model GrowBLOX units to its GB Sciences Nevada and GB Sciences Puerto Rico operations. With a $1.75 million funding commitment established via Pacific Leaf Ventures to get the company’s 4000 pounds per year Nevada-based Cultivation Lab up and running, as well as a clean, highly-efficient brick and mortar dispensary model known as The Apothecary in the works, and an advanced vending machine on the table that easily rivals or surpasses Medbox’s implementation (OTC: MDBX), GrowBLOX Sciences is already well on its way to becoming one of the top integrated operators in the industry.

Tight branding and marketing at the consumer level, combined with high-grade product and an ability to consistently produced scalable quantities for both direct consumption and drug development will be the keys to GBLX’s long-term success.

Learn more by visiting www.growblox.com

Let us hear your thoughts: GrowBLOX Sciences, Inc. Message Board

Appalachian Mountain Brewery is a growing player in the booming craft beer industry. Based in North Carolina, the company produces and distributes award-winning beer from its brewery and tasting room, as well as operates a food truck through its FarmToFlame subsidiary. Together, these two services combine to create a casual dining experience that elegantly balances innovation and sustainability. Additionally, the company plans to begin selling hard cider, which will be created from locally-grown North Carolina apples, through its Appalachian Mountain Cidery subsidiary in the coming weeks.

In recent years, the demand for craft beer has exploded. According to a report by the Brewers Association, craft beer sales grew by 17.6 percent to $19.6 billion in 2014. As a result of this growth, craft beer accounted for 11 percent of total beer sales throughout the United States. This market surge should provide HOPS with an opportunity to record strong financial results as it continues to expand its distribution network moving forward. In the first quarter of 2015, the company gave prospective shareholders a preview of its tremendous market potential when it posted an increase in gross profit of nearly 12 percent, as compared to the previous quarter.

In March, HOPS took a major step toward continued market growth when it announced a distribution agreement with Craft Brew Alliance, Inc. (NASDAQ: BREW), a leading craft brewing company, which will expand the company’s reach across North Carolina and beyond. By the end of 2015, the partnership is expected to facilitate the distribution of HOPS’s most popular brews throughout the Appalachian region.

“[Craft Brew Alliance] has built a phenomenal national network with its wholesaler partners, and we couldn’t be more excited to become a part of it as we continue to grow our business,” Sean Spiegelman, chief executive officer of HOPS, stated in a news release. “Through this agreement, we expect that [Appalachian Mountain Brewery] beer sales will grow exponentially as we increase distribution in key regions.”

With its recent efforts toward expanding its distribution network, HOPS represents an intriguing investment opportunity. Look for the company to leverage the strong performance of the national craft beer industry in order to promote continued financial growth and sustainable investor returns in the months to come.

For more information, visit www.appalachianmountainbrewery.com

Escalade, through its wholly-owned subsidiaries, is a leading manufacturer and distributor of sporting goods products, offering a full selection of basketball goals, archery equipment, indoor and outdoor game recreation and fitness products under a collection of industry-leading brands sold around the world. The company leverages an expansive distribution network – including sporting goods retailers, specialty dealers, online retailers, traditional department stores and mass merchants – to sell its products, helping it maintain a significant presence in the global sporting goods market for more than 80 years. In recent months, Escalade has leaned on this presence to promote strong financial growth and improved investor returns.

In the first quarter of 2015, Escalade demonstrated a commitment to increasing the strength of its brands by continuing to invest in product development. Through this strategy, the company was able to realize a 21 percent year-over-year increase in net sales, recording $33.4 million for the period. These results gave Escalade the financial flexibility to increase its quarterly dividend for all common stock in the future.

“We are pleased to increase our quarterly dividend payment based on the company’s strong financial performance,” Robert J. Keller, president and chief executive officer of Escalade, stated in a news release. “To achieve sustained growth in our markets, we will continue to make strategic investments in product line expansion and new category entry.”

Since its purchase of Kunkel Industries™ hand-pulled golf carts way back in 1966, Escalade has had tremendous success in promoting strong market growth through targeted acquisitions. Most recently, the company acquired Cue and Case Sales, Inc., a billiard accessory distributor serving the specialty dealer market, which immediately provided Escalade with access to a broadened and diversified customer base with which to continue building on its recent financial performance.

Last August, Escalade’s board of directors voted unanimously to focus exclusively on the sporting goods segment moving forward. Since the announcement of that decision, the company has posted increasingly strong financial results, making it an intriguing candidate for prospective investors. Look for Escalade to continue expanding its presence in the sporting goods market, providing a formidable platform for sustainable shareholder returns in the months to come.

For more information, visit www.escaladesports.com

FastFunds Financial today announced that its subsidiary, Pure Grow Systems, LLC, has been awarded an EPA Number. This number and its approved general label have been registered in the state of Nevada, allowing Pure Grow to sell its GroClean product within the state. Registration applications have also been filed in Colorado, Michigan, Oregon, Washington and Wisconsin.

“GroClean is just one of the anticipated products in the Pure Grow Systems product line,” FastFunds Financial CEO Harry Fong stated in the news release. “It provides the cannabis growing industry with new technology to clean, sanitize, and disinfect the growing and processing environments of plants and herbs used in the formulation of alternative, botanical, and herbal therapies.”

Pure Grow Systems is dedicated to the healthy production and processing of raw materials used for medicinal or other health-related purposes. When used as directed, GroClean kills mold, mildew, and harmful bacteria, such as salmonella and e-coli, in botanical and horticultural facilities, including hydroponic growing facilities.

Pure Grow Systems is on track to launch its website in 30 to 45 days.

For more information visit www.fastfundsfinancial.com

Let us hear your thoughts: Fastfunds Financial Corp. Message Board

OncoSec Medical, through the continued clinical development of its proprietary ImmunoPulse™ intratumoral cancer immunotherapy, is preparing to revolutionize the cancer treatment market. The company’s innovative therapeutic delivery system is designed to enhance local delivery and reception of DNA-based therapeutics through the use of electroporation, or electrical stimulation, meant to increase the permeability of the cell membrane. By supplying a sequence of short-duration electrical pulses to a tumor, ImmunoPulse has been shown effective in dramatically improving the uptake of DNA-based agents, thereby increasing the effectiveness of treatment options for various types of cancers by educating immune cells to recognize the disease.

To date, the company has primarily studied the benefits of its ImmunoPulse technology in combination with its DNA-based IL-12, a naturally occurring protein with immune-stimulating functions. OncoSec’s clinical pipeline currently includes phase II clinical studies of IL-12 for the treatment of metastatic melanoma, head and neck cancer and triple negative breast cancer. In early tests, the company has recorded promising results. In its multi-center phase II trial of IL-12 as a treatment for metastatic melanoma, half of all patients showed complete regression in at least one untreated lesion, demonstrating the immune-stimulating functions of the therapeutic. For OncoSec and its ImmunoPulse delivery system, these results could be just the beginning.

“While we work to advance our clinical studies, we are also continuing to explore the broader applications of our ImmunoPulse technology,” Punit Dhillon, president and chief executive officer of OncoSec, stated in a news release. “While our engineers work to develop advanced devices capable of accessing difficult-to-reach tumors, the discovery research team is investigating new DNA constructs and targets focused on defeating cancer’s ability to evade the immune system, allowing the patient’s immune system to recognize and attack the tumor.”

For prospective shareholders, the vast market potential of OncoSec’s therapeutic delivery system makes the company an intriguing investment opportunity moving forward. As of April 30, the company reported $25.4 million in cash and cash equivalents, which it expects will adequately fund operations for the next year. Additionally, the company’s uplisting to the NASDAQ Capital Market, which it completed in May, should provide a platform for increased visibility when the need for additional funding arises. With financial flexibility in place, OncoSec is in a strong position to make continued progress toward the eventual commercialization of its groundbreaking therapeutic pipeline in the coming months.

For more information, visit www.oncosec.com

Home prices are once again on the rise. According to a report by the United States Census Bureau, the average price of new home sales in May of this year was $337,000, marking the highest May average in recorded history. With statistics such as these in mind, Wisdom Homes of America, Inc. (OTCQB: WOFA) is working to make buying a home more affordable through the commercialization of readily-available manufactured homes in the Lone Star State.

In recent years, the market for manufactured homes has experienced tremendous growth, as more Americans are realizing the financial benefits of prefabricated housing options. In 2014, new manufactured home sales totaled approximately $4.1 billion, representing an increase of nearly 14 percent over the previous year. This surge can likely be attributed to the immense value offered by manufactured home solutions. According to WOFA’s website, home buyers can purchase a three bedroom, two bathroom home with vaulted ceilings and hardwood floors on a half-acre of prime real estate for just $120,000, which is a fraction of the average cost of comparable stick-built houses.

WOFA has leveraged the current condition of the housing market to post strong financial growth in recent months. In the second quarter of 2015, the company’s total revenue exceeded $1.2 million, and it expects to achieve revenues of at least $4 million by the end of the year. These results are particularly impressive when considering that WOFA has yet to complete its first full year of owning and operating home retail centers.

Moving forward, WOFA is in a strong strategic position to continue increasing its share of the national manufactured homes market. For prospective shareholders, the company’s early success in the retail distribution of prefabricated homes could foreshadow an opportunity to realize sustainable returns in the future. Look for WOFA to promote additional growth as it persists toward its goal of opening 30 retail centers in Texas and the surrounding states in the months to come.

For more information, visit www.wisdomhomesofamerica.com

Let us hear your thoughts: Wisdom Homes of America, Inc. Message Board

AmbiCom Holdings is a leading provider of optimization software solutions designed to improve the performance of complex IT environments, servers and personal computers. The company’s flagship product, Veloxum, has been certified by Microsoft (NASDAQ: MSFT), IBM (NYSE: IBM), VMware (NYSE: VMW) and Citrix (NASDAQ: CTXS) as an effective tool for maximizing performance, increasing workload density and minimizing costs for all levels of computer users. Through the development and commercialization of this product line, AmbiCom has access to a market that’s currently valued at nearly $69 billion, according to a report by Gartner Research.

Over the years, the PC optimization market has been plagued with less-than-helpful software scams, which have effectively limited the market potential of proven optimization solutions, such as Veloxum. In recent months, however, lawmakers have initiated a paradigm shift that could greatly increase the marketability of AmbiCom’s proprietary software in the future. Following dozens of court complaints by individuals and companies that were reportedly swindled for well over $120 million in deceptive threat detection computer programs, the FTC and the state of Florida took actions aimed at eliminating the marketability of these tech scams moving forward.

“We see this crackdown as great opportunity to introduce these consumers to a product that has been certified and verified as legitimate with actual results,” John Hwang, chairman and chief executive officer of AmbiCom, stated in a news release.

The Veloxum PC active optimization software, which was released in April, is a cloud-based offering that provides consumers with performance features that were previously only available to large enterprises. By automatically evaluating a computer’s workload and assets, the innovative software is able to tweak the manufacturer’s supplied settings in order to deliver enhanced performance. The current addressable market for AmbiCom’s PC offering includes more than 2.3 billion individual devices around the globe.

Earlier this week, AmbiCom expanded upon the potential marketability of its product portfolio by announcing Veloxum AO, a cloud-based active optimization solution for managed service providers (MSPs). This product, which is expected to be available for installation in August, will deliver the same performance features of AmbiCom’s previous solutions with added remote capability. There are currently an estimated 30,000 MSP firms worldwide generating approximately $251 billion in revenue, according to a report by Channeleyes.com.

“Every single computer, be it a PC or a server, can benefit from proper tuning,” stated Kevin Cornell, president of AmbiCom.

For prospective shareholders, AmbiCom’s continued growth in the computer optimization market should provide a strong platform for sustainable financial growth in the months to come.

For more information, visit www.ambicom.com